The Supreme Court Mifepristone Case Isn’t Just About Abortion
American ConservativeMar 22
SCOTUS Ruling Preserves Mifepristone Access
story
Image copyright: Anna Moneymaker/Staff/Getty Images News via Getty Images
The Facts
The US Supreme Court (SCOTUS) Thursday unanimously preserved access to the abortion pill Mifepristone.
In making an abortion-related ruling for the first time since it overturned Roe v. Wade's federal right to the procedure in 2022, SCOTUS decided the plaintiffs lacked the right to sue over the Food and Drug Administration's (FDA) approval of the pill.
The Spin
Left narrative
This might be a ruling to celebrate, but the elation unfortunately could be temporary. While it ruled the plaintiffs had no standing, the conservative wing of SCOTUS left the door open to a future challenge to the FDA's rules regarding mifepristone. This case should have been dismissed because it had so many holes in it — and future challenges should be given that treatment as well.
Right narrative
It's disappointing that SCOTUS hasn't held the FDA accountable. There are concerns that Mifepristone can bring numerous harms to women and doctors — many of whom have been abandoned by pro-abortion factions and the media. But this is just the first ruling, and future challenges to the drug's availability will hopefully lead to tighter restrictions and a safer environment for pregnant women.
